An official website of the United States government
PAR-19-315 - Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 3
Active NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|
Expired NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI) in Migraine and Headache Research | NOT-NS-22-051 | NINDS | Dec 27, 2021 | May 8, 2022 | U01, K01, UG3/UH3, K22, K99/R00, K02, K08, R01, F30, K23, F32, R21, F31, R61/R33 |
| Notice of Special Interest (NOSI) in NINDS mission relevant Pain Research | NOT-NS-22-050 | NINDS | Dec 27, 2021 | May 8, 2022 | K01, UG3/UH3, K99/R00, K22, K08, R01, K02, F30, K23, R21, F32, F31, U01, U24, R61/R33 |
| Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders | NOT-NS-22-010 | NINDS | Oct 1, 2021 | Jan 8, 2025 | R61/R33, U01, U44 |
